José Carreras Award handed out at the 17th Congress of EHA
The EHA Board has selected Professor Jesús San Miguel for the José Carreras Lecture at the 17th Congress in Amsterdam. Jesús San Miguel is Professor of Medicine (Haematology), Head of the Hematology Department at the University Hospital of Salamanca, and Director of the Biomedical Research Institute of Salamanca, Spain. He is an internationally recognized leader in the field of hematology, and specifically in the area of multiple myeloma.
He has made seminal contributions to myeloma cell biology. These included studies of the diagnostic and prognostic roles of immunophenotyping, morphology and molecular genetics together with investigation of disease evolution and the significance of minimal residual disease. In addition, in the area of therapeutics he has made major contributions to pivotal preclinical and clinical studies of new anti-myeloma drugs including proteasome inhibitors and chromatin modifying agents. He has provided international leadership through the generation of numerous guidelines on diagnosis, classification and treatment and was responsible for the creation of the International Staging System for multiple myeloma. He has published over 500 original papers in international journals with a median impact factor of 6.54 in the last five years.
Professor San-Miguel is a member of the Advisory board of the International Myeloma Foundation and the Multiple Myeloma Research Foundation. He has served on the board of the European Hematology Association, was Chairman of the Scientific Program Committee for the 9th Congress (2004) and was President of the 15th Congress in Barcelona (2010).
He has received numerous prizes including the Waldenström Award and the Spanish prizes on both oncology and translational research. The Waldenström award is a prestigious award in the field of multiple myeloma and is given by the International Myeloma Society to honor the contributions of an investigator in the field of multiple myeloma including biology and/or therapeutic. Professor San Miguel received the award in 2007.
In 2010 he received the Prize Severo Ochoa of Biomedical Research, which is given in memory of the Spanish Novel prize Severo Ochoa to the career of outstanding researchers. The International Myeloma Foundation has also distinguished Professor San Miguel with the "Kyle life achievement award" that recognizes the dedication through the entire scientific career to myeloma.
Professor San Miguel will present his lecture during the Opening Ceremony of the 17th Congress of EHA on Friday June 10 at 13:15 in Hall 3.